(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

2BIND

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

2BIND

ST13

US500000079399254

Class

1, 42

Filing

79399254

Registration

8016710

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

37

Latest update

07/16/2026

Trademark type

Combined

Nice classes

1, 42

Filing date

04/12/2024

Registration date

11/11/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/11/2025

Last transaction

07/16/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

5

Owner type

27

Owner location

Regensburg, DE

Examiner

HUDSON, TAMARA BREE

Law office

L40

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of "2BIND" in stylized font wherein the number "2" is in red and the word "BIND" is in blue and partially intermingled with the number "2".

Holders and representatives

Holders

2bind GmbH

Representatives

Miriam D. Trudell Davis Graham & Stubbs LLP

Technical classification

Nice Classes

Class 1Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemicalbiochemical and biological agentscompoundspreparationsreagents and substances for scientificresearchlaboratoryindustrial and commercial purposes ‘other than for medical and veterinary purposes; chemicalbiochemical and biological preparations for use in biophysical and biotechnological process for scientificresearchlaboratoryindustrial and commercial purposes; diagnostic reagentsbuffersbuffer solutionsbuffer-screening stock solutionsbioliquidsligandsHIV-immunogensantibodiesin particular therapeutic antibodiesmonoclonal antibodiesantibody reagentsproteinsaptamersantigensbiochemicals for in vitro and in vivo applications for scientificresearchlaboratoryindustrial and commercial purposesall the aforesaid except for medical and veterinary purposes; active chemical ingredients for use in the manufacture of anti-cancer drugs; chemicalbiochemical and biological agentscompoundspreparationsreagents and substances for the developmentmanufacture and research in the fields of biologybiotechnologybiochemistrychemistrypharmacy and cosmetics‘ other than for medical and veterinary purposes; chemicalbiochemical and biological agentscompoundspreparationsreagents and substances for scientific and medical research and for scientific research and development in the field of medicine; chemicalbiochemical and biological preparations for the research and development of biophysical and biotechnological products; chemicalbiochemical and biological agentscompoundspreparationsreagents and substances for the manufacture of medicine and pharmaceutical preparations; chemicalbiochemical and biological preparations for the manufacture of biophysical and biotechnological products; chemicals and chemical agentscompoundspreparationsreagents and substances for laboratory analysisin particular bacterial preparations and bacteriological preparationsexcept for medical and veterinary purposes

Class 42

Scientific research servicesconducting of biophysical interactions analyses for determining binding parameters of molecular interactions; scientific laboratory servicesplasmid cloningprotein expression in e.coliprotein purification and fluorescent protein marking; science and technology research services; research and development services in the fields of pharmacybiologymolecular biologygenetic sciencebiochemistrybiotechnologychemistryfood industry and cosmetology; medical and pharmaceutical research and development; scientifictechnological and industrial analysis and research in the fields of pharmacybiologymolecular biologygenetic sciencebiochemistrybiotechnologychemistryfood industryagrochemistry and cosmetology; scientific laboratory services; research laboratory services; analytical laboratory services; laboratory testing services for scientific research; scientific research in the nature of conducting of scientific experiments and tests; consultancy in the field of scientificindustrial and technological research and development; providing of information relating to industrial and scientific analysisresearch and development in the fields of pharmacybiologymolecular biologygenetic sciencebiochemistrybiotechnologychemistryfood industryagrochemistry and cosmetology; providing of information relating to technological research and development in the fields of pharmacybiologymolecular biologygenetic sciencebiochemistrybiotechnologychemistryfood industryagrochemistry and cosmetology; industrial development services in the fields of engineeringbiophysicsbioinformaticspharmacybiologymolecular biologygenetic sciencebiochemistrybiotechnologychemistryfood industryagrochemistry and cosmetology; conducting scientific studies for others in the fields of pharmacybiologymolecular biologygenetic sciencebiochemistrybiotechnologychemistryfood industryagrochemistry and cosmetology; development of industrial processes for others; development of new products for others; development of new technology for others; development and testing of chemicalbiochemical and biological manufacturing processes; research and development in the nature of developing testing methods and research and development services for developing methods of testing; development of machining techniques; research and development relating to medicinespharmaceuticalsmedical goodsdiagnosticsdiagnostic and analysis goodsfoodcosmeticscleaning preparations and disinfectants; research and development services and industrialscientific and technological laboratory services relating to protein and RNA-based medicine developmentantibody developmentprotein analysisaptamer development and the determination of molecular interactions

Publications

History of USPTO decisions and trademark events.

37 publications found

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

07/16/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

06/29/2026

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

06/29/2026

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

06/11/2026

FICS

FINAL DISPOSITION NOTICE SENT TO IB

05/25/2026

FIMP

FINAL DISPOSITION PROCESSED

05/25/2026

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

02/11/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

01/01/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

11/11/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

11/11/2025

ATRV

ATTORNEY REVIEW COMPLETED

09/29/2025

CREV

CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED

09/29/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/23/2025

PUBO

PUBLISHED FOR OPPOSITION

09/23/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/17/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/25/2025

CORR

CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED

08/23/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/05/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/05/2025

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

08/05/2025

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

03/28/2025

GNFR

FINAL REFUSAL E-MAILED

03/28/2025

CNFR

FINAL REFUSAL WRITTEN

03/28/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/17/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/17/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/17/2025

CRCV

CORRECTION TRANSACTION RECEIVED FROM IB

01/31/2025

RFNT

REFUSAL PROCESSED BY IB

11/30/2024

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

11/11/2024

RFRR

REFUSAL PROCESSED BY MPU

11/11/2024

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

11/02/2024

CNRT

NON-FINAL ACTION WRITTEN

11/01/2024

DOCK

ASSIGNED TO EXAMINER

10/25/2024

CRCV

CORRECTION TRANSACTION RECEIVED FROM IB

09/20/2024

MAFR

APPLICATION FILING RECEIPT MAILED

07/11/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/11/2024

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

07/04/2024

Continuous trademark protection

Get notified about every new filing that threatens 2BIND or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.